• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SmileDirectClub Reports Third Quarter 2022 Financial Results

    11/7/22 4:01:00 PM ET
    $SDC
    Medical/Dental Instruments
    Health Care
    Get the next $SDC alert in real time by email

    Disciplined Cost Management Drove Improving Cash Flow

    Raises Midpoint of 2022 Revenue and Adjusted EBITDA Guidance

    NASHVILLE, Tenn., Nov. 07, 2022 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced its financial results for the third quarter ended September 30, 2022.

    Third Quarter 2022 Financial Highlights

    • Total revenue of $107 million, a 15.1% decrease over the second quarter of 2022 and a decrease of 22.5% over the prior year period.
    • Net loss of $(70) million, an increased loss of $4 million over the second quarter of 2022 and an improvement of $20 million over the prior year period.
    • Adjusted EBITDA of $(30) million, a $7 million decrease over the second quarter of 2022, and an improvement of $24 million over the prior year period.
    • Diluted EPS of $(0.18), a decrease of $0.01 over the second quarter of 2022, and an improvement of $0.05 over the prior year period.
    • Net cash used in operating activities was $(24) million, an increase of $6 million over the second quarter of 2022 and an improvement of $15 million over the prior year period.
    • Free Cash Flow defined as net cash used in operating activities less net cash used in investing activities of $(35) million, an improvement of $1 million over the second quarter of 2022 and an improvement of $29 million over the prior year period

    Key Operating Metrics and Strategic Highlights

    • Third quarter unique aligner shipments of 52,367, a 16.5% sequential decrease over 62,705 shipments in the second quarter of 2022.
    • Third quarter average aligner gross sales price ("ASP") of $1,902 compared to $1,917 for the second quarter of 2022.

    "Our team delivered both revenue and bottom-line results that are on track with our updated outlook provided on our second quarter call. We are raising our full year 2022 midpoint guidance for revenue and adjusted EBITDA based on better traction with customers driven by improving marketing efficiencies. Our disciplined cost management enabled us to produce improved year-over-year bottom line results despite top line headwinds," said David Katzman, Chief Executive Officer and Chairman of SmileDirectClub. "During the third quarter, our team made great progress on our key growth initiatives. Our innovative SmileMaker mobile scanning app for 3D treatment planning is on track to launch in a test market in the fourth quarter with an expanded geographic release in early 2023. Our in-person, premium aligner offering SmileDirectClub Care+ is targeted for test market release in the first quarter of 2023. This solution and value proposition has resonated well within the dental industry as we continue to build scale in our partner network by adding 260 new partners in the third quarter, with growing provider interest in joining the network even before the official launch of Care+."

    Business Outlook

    SmileDirectClub's mission is to democratize access to a smile each and every person loves and deserves by making it affordable and convenient for everyone. The aspirational vision of the Company's organization is to become the "world's leading oral health brand by helping more people realize the life changing potential of a confident smile." SmileDirectClub's vision and mission are much greater than manufacturing and marketing clear aligners. Every decision and investment the Company has made is to support and expand this mission and enable its long-term growth potential. For SmileDirectClub to realize the Company's vision through its mission, the Company must expand its reach within and beyond the Company's existing core customer base. Expanding reach comes through continuously bringing transformative innovation to the market across an entire portfolio of both consumer facing and non-consumer facing innovations through the Company's focus on Partner Network, aligner product innovations, Care+ and oral care solutions. SmileDirectClub possesses the unique assets and innovation to disrupt the incumbents, the agility to adjust to the needs of its customer, and a sustainable brand that is top of mind with consumers.  

    The Company has been issued 46 patents and counting for its innovations in orthodontic treatment planning, aligner manufacturing, smile scanning technologies, its proprietary telehealth platform and a variety of other areas. There are many more patents pending and in the pipeline in both the U.S. and abroad on various technologies relating to data capture, 3D image capture, intraoral scanning, monitoring, manufacturing, and consumer products. In addition, the Company has enabled treatment for over 1.8 million customers, built the only end-to-end vertically integrated platform for the consumer at scale, created a Dental Partner Network with 950 global practices that are live or pending training, created oral care products available at over 16,300 retail stores worldwide, and remains the strongest teledentistry brand with 58% aided awareness. Demand for medical professionals to join SmileDirectClub's Partner Network has been strong with 260 new partners added in the third quarter and a robust pipeline of additional practice interest even before the launch of the Care+ offering.

    When consumers are considering straightening their teeth, they typically do one or all of the following: search online to understand their options; ask a dentist; ask a friend or family member which option they should choose. Based on the Company's research, consumers have noted its product and customer experience is nearly identical to Invisalign, less expensive, and more convenient. Compared to other teledentistry platforms, research showed that significantly fewer customers would recommend those brands to their friends and family compared with SmileDirectClub customer recommendations. A first quarter consumer brand survey separately noted that the SmileDirectClub's unaided and aided brand awareness continues to increase from and surpass its teledentistry competitors and close in on the brand awareness recognition of category originator Invisalign. Additionally, the Company's pioneering telehealth platform was recently recognized by MedTech Breakthrough, winning the "Best Telehealth Platform" award in 2022.

    In addition to these investments to create the next generation of oral care and influence consumer decision making, the Company will continue to make strategic investments in penetrating new demographics to drive controlled growth, while also executing against its profitability goals. Lastly, favorable industry dynamics continue to increase with broader acceptance of telehealth and specifically teledentistry, minimal penetration against the total addressable market, a number of recent regulatory wins that helped remove barriers to access to care, and clear aligners gaining share in the overall industry.

    Revised Full Year 2022 Guidance

    Challenges to consumer spending and sustained high inflation continue to impact our overall expected demand for the balance of the year. Our third quarter results were as expected and with only two months left in the year, we are tightening our full year 2022 outlook.

    For the year ended December 31, 2022, the Company expects total revenue to be in the range of $470 million to $500 million.

    The full year 2022 costs and capital outlook include (see Company's supplemental earnings presentation for more insights regarding these assumptions):

    • Gross margin range (as a percentage of total revenues) of 70.5% to 71.5%
    • Adjusted EBITDA range of ($155 million) to ($135 million)
    • CapEx range of $55 million to $60 million
    • One-time costs range of $20 million to $25 million
    • Year-end cash balance between $110 million to $130 million

    Year-end cash guidance includes an estimated $60 million to $70 million from outside funding, primarily coming from utilization of the outstanding HPS facility.

    Conference Call Information

    SmileDirectClub Third Quarter 2022 Conference Call Details
      
    Date:November 8, 2022
    Time:8:00 a.m. Eastern Time (7:00 a.m. Central Time)
    Dial-In: 1-877-407-9208 (domestic) or 1-201-493-6784 (international)
    Webcast: Visit "Events and Presentations" section of the company's IR page at http://investors.smiledirectclub.com

    A replay of the call may be accessed the same day from 11 a.m. Eastern Time on Tuesday, November 8, 2022 until 11:59 p.m. Eastern Time on Tuesday, November 15, 2022 by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and entering the replay PIN: 13733253. A copy of the third quarter 2022 results supplemental earnings presentation and an archived version of the call, when completed, will also be available on the Investor Relations section of SmileDirectClub's website at investors.smiledirectclub.com.

    Forward-Looking Statements

    This earnings release contains forward-looking statements. All statements other than statements of historical facts may be forward-looking statements. Forward-looking statements generally relate to future events and include, without limitation, projections, forecasts and estimates about possible or assumed future results of our business, financial condition, liquidity, results of operations, plans, and objectives. Some of these statements may include words such as "expects," "anticipates," "believes," "estimates," "targets," "plans," "potential," "intends," "projects," and "indicates."

    Although they reflect our current, good faith expectations, these forward-looking statements are not a guarantee of future performance, and involve a number of risks, uncertainties, estimates, and assumptions, which are difficult to predict. Some of the factors that may cause actual outcomes and results to differ materially from those expressed in, or implied by, the forward-looking statements include, but are not necessarily limited to: the ongoing assessment of the cyber incident, material legal, financial and reputational risks resulting from such incident and the related operational disruptions; the duration and magnitude of the COVID-19 pandemic and related containment measures; our management of growth; the execution of our business strategies, implementation of new initiatives, and improved efficiency; our sales and marketing efforts; our manufacturing capacity, performance, and cost; our ability to obtain future regulatory approvals; our financial estimates and needs for additional financing; consumer acceptance of and competition for our clear aligners; our relationships with retail partners and insurance carriers; our R&D, commercialization, and other activities and expenditures; the methodologies, models, assumptions, and estimates we use to prepare our financial statements, make business decisions, and manage risks; laws and regulations governing remote healthcare and the practice of dentistry; our relationships with vendors; the security of our operating systems and infrastructure; our risk management framework; our cash and capital needs; our intellectual property position; our exposure to claims and legal proceedings; and other factors described in our filings with the Securities and Exchange Commission, including but not limited to our Annual Report on Form 10-K for the year ended December 31, 2021 and our Form 10-Q for the period ended September 30, 2022.

    About SmileDirectClub

    SmileDirectClub, Inc. (NASDAQ:SDC) ("SmileDirectClub") is an oral care company and creator of the first medtech platform for teeth straightening. Through its cutting-edge telehealth technology and vertically integrated model, SmileDirectClub is revolutionizing the oral care industry. SmileDirectClub's mission is to democratize access to a smile each and every person loves by making it affordable and convenient for everyone. For more information, please visit SmileDirectClub.com.

    Investor Relations:

    Jesse Weaver

    Senior Vice President, Finance and Treasury

    Jonathan Fleetwood

    Director, Investor Relations

    [email protected]

    Media Relations:

    Kim Atkinson

    Senior Vice President, Global Communications

    [email protected] 



    SmileDirectClub, Inc.

    Condensed Consolidated Balance Sheets

    (in thousands)

    (unaudited)

     September 30,December 31,
     2022  2021 
    ASSETS  
    Cash$120,181 $224,860 
    Accounts receivable, net 152,531  184,558 
    Inventories 44,242  40,803 
    Prepaid and other current assets 21,085  17,519 
    Total current assets 338,039  467,740 
    Accounts receivable, net, non-current 49,249  59,210 
    Property, plant and equipment, net 202,514  227,201 
    Operating lease right-of-use assets 22,810  24,927 
    Other assets 19,184  15,480 
    Total assets$631,796 $794,558 
    LIABILITIES AND EQUITY (DEFICIT)  
    Accounts payable$36,097 $19,922 
    Accrued liabilities 86,258  122,066 
    Deferred revenue 14,507  20,258 
    Current portion of long-term debt 4,217  10,997 
    Other current liabilities 6,703  4,997 
    Total current liabilities 147,782  178,240 
    Long-term debt, net of current portion 788,164  729,973 
    Operating lease liabilities, net of current portion 16,973  20,352 
    Other long-term liabilities 746  347 
    Total liabilities 953,665  928,912 
    Equity (Deficit)  
    Class A common stock, par value $0.0001 and 121,420,358 shares issued and outstanding at September 30, 2022 and 119,280,781 shares issued and outstanding at December 31, 2021 12  12 
    Class B common stock, par value $0.0001 and 268,823,501 shares issued and outstanding at September 30, 2022 and 269,243,501 shares issued and outstanding at December 31, 2021 27  27 
    Additional paid-in-capital 467,946  448,867 
    Accumulated other comprehensive income 741  293 
    Accumulated deficit (359,881) (295,321)
    Noncontrolling interest (448,334) (305,852)
    Warrants 17,620  17,620 
    Total equity (deficit) (321,869) (134,354)
    Total liabilities and equity (deficit)$631,796 $794,558 



    SmileDirectClub, Inc.

    Condensed Consolidated Statements of Operations

    (in thousands, except share and per share amounts)

    (unaudited)

     Three Months Ended September 30,Nine Months Ended September 30,
     2022  2021  2022  2021 
    Revenue, net$98,524 $126,796 $357,838 $478,185 
    Financing revenue 8,246  10,887  26,374  33,140 
    Total revenues 106,770  137,683  384,212  511,325 
    Cost of revenues 31,995  39,412  109,136  133,233 
    Gross profit 74,775  98,271  275,076  378,092 
    Marketing and selling expenses 58,212  96,175  226,114  289,241 
    General and administrative expenses 75,507  85,658  218,620  251,778 
    Lease abandonment and impairment of long-lived assets 197  1,378  1,429  1,378 
    Restructuring and other related costs 3,169  95  17,869  1,759 
    Loss from operations (62,310) (85,035) (188,956) (166,064)
    Interest expense 5,360  1,772  11,370  21,277 
    Loss on extinguishment of debt —  —  —  47,631 
    Other expense 1,323  2,695  8,564  3,737 
    Net loss before provision for income tax expense (benefit) (68,993) (89,502) (208,890) (238,709)
    Provision for income tax expense (benefit) 739  (119) (468) 1,576 
    Net loss (69,732) (89,383) (208,422) (240,285)
    Net loss attributable to noncontrolling interest (48,058) (61,991) (143,862) (167,104)
    Net loss attributable to SmileDirectClub, Inc.$(21,674)$(27,392)$(64,560)$(73,181)
         
    Earnings (loss) per share of Class A common stock:    
    Basic$(0.18)$(0.23)$(0.53)$(0.62)
    Diluted$(0.18)$(0.23)$(0.53)$(0.62)
         
    Weighted average shares outstanding:    
    Basic 121,163,578  118,918,072  120,729,146  118,081,711 
    Diluted 389,987,079  388,161,573  389,654,332  387,554,625 



    SmileDirectClub, Inc.

    Condensed Consolidated Statements of Cash Flows

    (in thousands)

    (unaudited)

     Nine Months Ended September 30,
     2022  2021 
    Operating Activities  
    Net loss$(208,422)$(240,285)
    Adjustments to reconcile net loss to net cash used in operating activities:  
    Depreciation and amortization 57,609  51,655 
    Deferred loan cost amortization 4,239  4,069 
    Equity-based compensation 21,559  37,659 
    Loss on extinguishment of debt —  47,631 
    Paid in kind interest expense 626  3,324 
    Asset impairment and related charges 2,905  1,378 
    Other non-cash operating activities 2,117  977 
    Changes in operating assets and liabilities:  
    Accounts receivable 41,988  30,845 
    Inventories (3,439) (9,706)
    Prepaid and other current assets (3,548) (10,062)
    Accounts payable 18,106  (20,984)
    Accrued liabilities (34,693) 9,827 
    Deferred revenue (5,751) (4,395)
    Net cash used in operating activities (106,704) (98,067)
    Investing Activities  
    Purchases of property, equipment, and intangible assets (40,168) (70,284)
    Net cash used in investing activities (40,168) (70,284)
    Financing Activities  
    Repurchase of Class A shares to cover employee tax withholdings (2,953) (9,055)
    Proceeds from stock purchase plan 481  632 
    Repayment of HPS Credit Facility —  (396,497)
    Payment of extinguishment costs —  (37,701)
    Borrowings of long-term debt 54,920  747,500 
    Payments of issuance costs (5,482) (21,179)
    Purchase of capped call transactions —  (69,518)
    Final payment of Align arbitration —  (43,400)
    Principal payments on long-term debt —  (4,609)
    Payments of finance leases (6,780) (8,046)
    Other 1,820  684 
    Net cash provided by financing activities 42,006  158,811 
    Effect of exchange rates change on cash and cash equivalents 187  464 
    Decrease in cash (104,679) (9,076)
    Cash at beginning of period 224,860  316,724 
    Cash at end of period$120,181 $307,648 

    Use of Non-GAAP Financial Measures

    This earnings release contains certain non-GAAP financial measures, including adjusted EBITDA ("Adjusted EBITDA") and Free Cash Flow. We provide a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures below and in our Current Report on Form 8-K announcing our quarterly earnings results, which can be found on the SEC's website at www.sec.gov and our website at investors.smiledirectclub.com.

    We utilize certain non-GAAP financial measures, including Free Cash Flow and Adjusted EBITDA, to evaluate our actual operating performance and for the planning and forecasting of future periods.

    We define Free Cash Flow as net cash used in operating activities less net cash used in investing activities.

    We define Adjusted EBITDA as net loss, plus depreciation and amortization, interest expense, income tax expense (benefit), equity-based compensation, loss on extinguishment of debt, impairment of long-lived assets, abandonment and other related charges and certain other non-operating expenses, such as one-time store closure costs associated with our real estate repositioning strategy, severance, retention and other labor costs, certain one-time legal settlement costs, and unrealized foreign currency adjustments. We use Adjusted EBITDA when evaluating our performance when we believe that certain items are not indicative of operating performance. Adjusted EBITDA provides useful supplemental information to management regarding our operating performance, and we believe it will provide the same to members/stockholders.

    We believe that Adjusted EBITDA will provide useful information to members/stockholders about our performance, financial condition, and results of operations for the following reasons: (i) Adjusted EBITDA is among the measures used by our management team to evaluate our operating performance and make day-to-day operating decisions and (ii) Adjusted EBITDA is frequently used by securities analysts, investors, lenders, and other interested parties as a common performance measure to compare results or estimate valuations across companies in our industry.

    Adjusted EBITDA does not have a definition under GAAP, and our definition of Adjusted EBITDA may not be the same as, or comparable to, similarly titled measures used by other companies. Adjusted EBITDA should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP.

    A reconciliation of both Free Cash Flow and Adjusted EBITDA to net loss, the most directly comparable GAAP financial measure for Adjusted EBITDA, is set forth below.

    SmileDirectClub, Inc.

    Reconciliation of Free Cash Flow

    (in thousands)  

     Three Months Ended
    September 30, 2022June 30, 2022September 30, 2021
    Net Cash used in operating activities$(24,100)$(17,840)$(38,716)
    Net Cash used in investing activities (10,796) (17,754) (24,981)
    Free Cash Flow$(34,896)$(35,594)$(63,697)



    SmileDirectClub, Inc.

    Reconciliation of Net Loss to Adjusted EBITDA

    (in thousands)

     Three Months Ended September 30,Nine Months Ended September 30,
     2022  2021  2022  2021 
    Net loss$(69,732)$(89,383)$(208,422)$(240,285)
    Depreciation and amortization 19,113  18,486  57,609  51,655 
    Total interest expense 5,360  1,772  11,370  21,277 
    Income tax expense (benefit) 739  (119) (468) 1,576 
    Lease abandonment and impairment of long-lived assets 197  1,378  1,429  1,378 
    Restructuring and other related costs 3,169  95  17,869  1,759 
    Loss on extinguishment of debt —  —  —  47,631 
    Equity-based compensation 7,693  10,492  21,559  37,659 
    Other non-operating general and administrative losses 3,788  3,264  11,778  5,777 
    Adjusted EBITDA$(29,673)$(54,015)$(87,276)$(71,573)


    Primary Logo

    Get the next $SDC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SDC

    DatePrice TargetRatingAnalyst
    3/30/2022$2.00Hold → Sell
    Loop Capital
    3/2/2022$2.29 → $2.20Equal-Weight
    Morgan Stanley
    3/2/2022$5.00 → $3.00Equal-Weight
    Stephens & Co.
    1/31/2022$2.29Equal-Weight
    Morgan Stanley
    1/25/2022Sell → Hold
    Craig Hallum
    1/7/2022$11.00 → $4.00Outperform
    Credit Suisse
    11/9/2021$6.00 → $5.00Hold
    Stifel
    11/9/2021$4.00 → $2.00Sell
    Goldman
    More analyst ratings

    $SDC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by SmileDirectClub Inc. (Amendment)

      SC 13G/A - SmileDirectClub, Inc. (0001775625) (Subject)

      2/14/23 4:00:19 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by SmileDirectClub Inc.

      SC 13G - SmileDirectClub, Inc. (0001775625) (Subject)

      3/2/22 4:00:29 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by SmileDirectClub Inc. (Amendment)

      SC 13G/A - SmileDirectClub, Inc. (0001775625) (Subject)

      2/10/22 8:37:48 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care

    $SDC
    SEC Filings

    See more
    • SEC Form 25-NSE filed by SmileDirectClub Inc.

      25-NSE - SmileDirectClub, Inc. (0001775625) (Subject)

      12/27/23 9:03:29 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - SmileDirectClub, Inc. (0001775625) (Filer)

      10/2/23 5:18:43 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - SmileDirectClub, Inc. (0001775625) (Filer)

      9/29/23 6:35:50 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care

    $SDC
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $SDC
    Financials

    Live finance-specific insights

    See more

    $SDC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $SDC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SmileDirectClub Seeks to Execute Comprehensive Recapitalization to Strengthen the Business for Sustainable Growth

      NASHVILLE, Tenn., Sept. 29, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care Company with the first medtech platform for teeth straightening, today announced a process to implement a comprehensive recapitalization transaction. The additional capital and stronger financial position from this recapitalization is intended to bolster the Company's balance sheet and fuel growth initiatives to allow SmileDirectClub to thrive as an international oral care leader for many years to come. SmileDirectClub will seek to recapitalize through a transaction where the Company's founders have committed to invest at least $20 million to bolster the Company's balance

      9/29/23 6:31:33 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub To Appeal Decision In Align Technology Arbitration

      NASHVILLE, Tenn., Aug. 24, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub (NASDAQ:SDC), the oral care leader and creator of the first med tech platform for teeth straightening, announced its intention to appeal a decision regarding an award of $63 million to be paid to Align Technology following a dispute over the Company's exclusive supply agreement with its former strategic partner. "SmileDirectClub is disappointed with the California trial court's recent rulings denying our Petition to Vacate and granting the Petition to Confirm the Final Award in an arbitration Align brought against SmileDirectClub for alleged breaches of a Supply Agreement between the parties that expired in 2019," said Su

      8/24/23 5:25:00 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub Reports Second Quarter 2023 Financial Results

      NASHVILLE, Tenn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced its financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Financial Highlights Total revenue of $102 million, a 15.0% decrease over the first quarter of 2023 and a decrease of 19.1% over the prior year period. The sequential seasonal decline improved compared to last year despite the first quarter of 2023 overperforming expectations.Net loss improvement of $12 million over the prior year period at $(54) million in the second quarter of 2023.Adjusted EBITDA improvem

      8/8/23 4:01:00 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub Reports Second Quarter 2023 Financial Results

      NASHVILLE, Tenn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced its financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Financial Highlights Total revenue of $102 million, a 15.0% decrease over the first quarter of 2023 and a decrease of 19.1% over the prior year period. The sequential seasonal decline improved compared to last year despite the first quarter of 2023 overperforming expectations.Net loss improvement of $12 million over the prior year period at $(54) million in the second quarter of 2023.Adjusted EBITDA improvem

      8/8/23 4:01:00 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub to Report Second Quarter 2023 Results on August 8, 2023

      NASHVILLE, Tenn., July 07, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, announced today it will report results for the second quarter 2023 on Tuesday, August 8, 2023, after close of market. David Katzman, SmileDirectClub's Chief Executive Officer and Chairman, and Troy Crawford, SmileDirectClub's Chief Financial Officer, will host a conference call to discuss these results on Wednesday, August 9, 2023, at 8 a.m. Eastern Time. SmileDirectClub Second Quarter 2023 Conference Call DetailsDate: Wednesday, August 9, 2023Time: 8 a.m. Eastern Time (7 a.m. Central Time)Dial-In: 1-877

      7/7/23 8:01:00 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub Reports First Quarter 2023 Financial Results

      NASHVILLE, Tenn., May 09, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced its financial results for the first quarter ended March 31, 2023. Revenue for the first quarter of 2023 increased 38.4% compared to the fourth quarter of 2022 with gross profit up 64.6% for the same period. For the first quarter 2023, disciplined cost management allowed the Company to deliver a $7 million improvement in Net Loss and an $8 million improvement in Adjusted EBITDA compared to the first quarter of 2022 despite a decline in revenue year-over-year. Net Cash used in operating activit

      5/9/23 4:01:00 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Wallman Richard F

      4 - SmileDirectClub, Inc. (0001775625) (Issuer)

      6/23/23 4:01:59 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Ward Edward W Iii

      4 - SmileDirectClub, Inc. (0001775625) (Issuer)

      6/5/23 4:23:16 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Williams Linda Marie

      4 - SmileDirectClub, Inc. (0001775625) (Issuer)

      6/5/23 4:22:29 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub downgraded by Loop Capital with a new price target

      Loop Capital downgraded SmileDirectClub from Hold to Sell and set a new price target of $2.00

      3/30/22 7:52:04 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • Morgan Stanley reiterated coverage on SmileDirectClub with a new price target

      Morgan Stanley reiterated coverage of SmileDirectClub with a rating of Equal-Weight and set a new price target of $2.20 from $2.30 previously

      3/2/22 10:22:00 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • Stephens & Co. reiterated coverage on SmileDirectClub with a new price target

      Stephens & Co. reiterated coverage of SmileDirectClub with a rating of Equal-Weight and set a new price target of $3.00 from $5.00 previously

      3/2/22 7:21:27 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care

    $SDC
    Leadership Updates

    Live Leadership Updates

    See more
    • Holley Announces Appointment of Jesse Weaver as Chief Financial Officer

      Holley Inc. (NYSE:HLLY), the leading platform serving performance automotive enthusiasts, today announced the appointment of Jesse Weaver as the Company's Chief Financial Officer. Mr. Weaver will succeed Stephen Trussell, who has served as the Company's Interim Chief Financial Officer since September 30, 2022. Mr. Trussell will continue as the Company's Vice President of Finance, a role he has held since 2009. Mr. Weaver, who has nearly 20 years of experience in finance, strategy, and data analytics, will serve as a member of the executive leadership team and report directly to President and Chief Executive Officer, Tom Tomlinson. Most recently, Mr. Weaver served as Senior Vice President o

      12/12/22 4:01:00 PM ET
      $DG
      $HLLY
      $SDC
      $YUM
      Department/Specialty Retail Stores
      Consumer Discretionary
      Auto Parts:O.E.M.
      Medical/Dental Instruments
    • SmileDirectClub Appoints Azmat Ali as Vice President of Product

      NASHVILLE, Tenn., Oct. 10, 2022 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced the appointment of Azmat Ali as Vice President of Product. Mr. Ali will play a significant role in enhancing the customer experience by fueling the Company's innovation portfolio with high-quality aligners, retainers, and new opportunities that complement the Company's existing offerings. Mr. Ali is a results-driven product marketing executive with experience leading organizations through change and growth. As VP of Product, he will own the product vision, roadmap, and customer experience fo

      10/10/22 8:00:00 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub Announces Appointment of Alex Dimitrief to Board of Directors

      NASHVILLE, Tenn., July 25, 2022 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced the appointment of Alex Dimitrief as an independent director on its Board of Directors, effective immediately. Mr. Dimitrief is an experienced director and C-suite leader with a track record of steering global businesses through a wide range of challenges. He currently serves as a Partner at Zeughauser Group, a Lecturer on Law at Harvard Law School, and a Senior Fellow and Distinguished Adjunct Professor at the New York Law School. From 2007 to 2019, Mr. Dimitrief served in several business

      7/25/22 8:01:00 AM ET
      $EOSE
      $SDC
      Industrial Machinery/Components
      Miscellaneous
      Medical/Dental Instruments
      Health Care